These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects. Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833 [TBL] [Abstract][Full Text] [Related]
38. Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: a prospective 12-month paired TMS study. Bares M; Kanovský P; Rektor I Parkinsonism Relat Disord; 2007 Dec; 13(8):489-94. PubMed ID: 17449315 [TBL] [Abstract][Full Text] [Related]
39. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up]. Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540 [TBL] [Abstract][Full Text] [Related]
40. Autonomic nervous function in de novo parkinsonian patients in basal condition and after acute levodopa administration. Quadri R; Comino I; Scarzella L; Cacioli P; Zanone MM; Pipieri A; Bergamasco B; Chiandussi L Funct Neurol; 2000; 15(2):81-6. PubMed ID: 10916719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]